CTPL CEO Announcement

The Board of Cell Therapies Pty Ltd (CTPL) have announced that due to the ongoing covid-related travel restrictions, which have been particularly restrictive for residents of WA, Dr Dawn Driscoll will be stepping down from her post as CEO, effective 31 Dec 2020. A. Prof. Leslie Reti AM, Chairman, said “The Board, Management and Staff of CTPL would like to thank Dawn for her commitment and stewardship of the company from a much smaller but highly specialised manufacturer and distributor of cell based therapies, to a significantly larger and more robust, globally-active commercial contract development and manufacturing company, over her past 3 years as CEO.”

The recruitment of a new CEO will occur in due course and an announcement will be made as soon as practicable. A. Prof. Dominic Wall will be Acting CEO from 1st of January 2021 until the new CEO commences.